Presentations from 31st Annual International Prostate Cancer Update

SESSION 1: Men’s Prostate Health

Diet Only and Prostate Cancer

Mark A. Moyad, MD, MPH, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

The Third Dimension in Prostate Cancer Diagnosis

Francisco G. La Rosa, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Early Diagnosis of Prostate Cancer: A Path Forward

E. David Crawford, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

The Prostate – Highlights of Prostate Cancer Advances As Covered in ASCO-SEP

Marc B. Garnick, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Patient Advocacy: Advocate Perspective

Wendy L. Poage, MHA, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

LUGPA Government Policy Panel

R. Jonathan Henderson, MD, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 2: Biomarkers and Genetic Testing

Prostate Cancer Early Detection 2021

Peter R. Carroll, MD, MPH, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

What’s New in Active Surveillance for Prostate Cancer in 2021

Laurence Klotz, MD, FRCSC, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Genetic Testing and Prostate Cancer

Raoul S. Concepcion, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Germline Genetics in Prostate Cancer

Brian T. Helfand, MD, PhD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Prostate Cancer Risk Assessment: Focus on Early PSA and Hereditary Risk

Gerald L. Andriole, Jr., MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Use of Polygenic Risk Scores for Prostate Cancer Screening

Peter R. Carroll, MD, MPH, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Review of Sentinel Assay

Laurence Klotz, MD, FRCSC, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion: Biomarkers and Genetic Testing

Alan H. Bryce, MD, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 3: Practice Management

LUGPA Government Policy Panel

R. Jonathan Henderson, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel on Starting an Advanced Prostate Cancer Clinic

Scott B. Sellinger, MD, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Negotiating Pay for Call Contracts with Hospitals

Evan R. Goldfischer, MD, MBA, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Private Equity Panel Discussion

Deepak A. Kapoor, MD, FACS, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

How to Optimize a Telehealth Visit

Evan R. Goldfischer, MD, MBA, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Telemedicine and Post-COVID Treatment Panel Discussion

Mara R. Holton, MD, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 4: Localized Prostate Cancer, Including ADT and Radiation Oncology

Updates in ADT: Managing Adverse Effects

Laurence Klotz, MD, FRCSC, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Role of ADT with Radiation

Steven E. Finkelstein, MD, FACRO, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

ADT Panel Discussion

Raoul S. Concepcion, MD, FACS, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Active Surveillance in Favorable Intermediate-Risk Prostate Cancer

James A. Eastham, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Can We Trust TRUS Biopsies?

Francisco G. La Rosa, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion: Management of High-Risk, Non-Metastatic Prostate Cancer – The Case for Surgery

James A. Eastham, MD, FACS, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Management of Biochemical Recurrence After Surgery or Radiation

Peter R. Carroll, MD, MPH, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Contemporary Brachytherapy: A View from the ABS

Brian J. Moran, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Updates in Radiation Oncology: A View From ACRO

Steven E. Finkelstein, MD, FACRO, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 5: Next Generation Imaging: Focus on PSMA

Next Generation Imaging

Phillip J. Koo, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Current Status of PSMA Diagnostics

Jérémie Calais, MD, MSc, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Next Generation Imaging in Prostate Cancer: PYLARIFY

E. David Crawford, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion – Focus on PSMA

Phillip J. Koo, MD, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

PSMA PET Imaging at Time of Diagnosis

Peter R. Carroll, MD, MPH, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Management of Oligometastatic Disease

Robert E. Reiter, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Radiation Oncology Perspective: Update on Prostate Cancer Image Guided Metastasis-Directed Therapy

Steven E. Finkelstein, MD, FACRO, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion with Cases

Phillip J. Koo, MD, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Phase 3 VISION Study of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer

Daniel J. George, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Future Trials with Lutetium-177

Daniel P. Petrylak, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Radium-223 Trial Updates

Daniel P. Petrylak, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Integrating Theranostics Into a Group Practice

David M. Albala, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion: PSMA and Other Therapies

Phillip J. Koo, MD, moderated this panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 6: Advanced Imaging

Treatment for Prostate Cancer with MRI-Guided Transurethral Ultrasound

Laurence Klotz, MD, FRCSC, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

High-Resolution 29 MHZ Micro-Ultrasound in Diagnosis of Primary and Recurrent Prostate Cancer

Gerald L. Andriole, Jr., MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

MRI: Can It Be Used to Plan Ablative Therapies?

Robert E. Reiter, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Next Generation Imaging for Localization of Recurrent Prostate Cancer

Brian T. Helfand, MD, PhD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion – Advanced Imaging

Robert E. Reiter, MD, moderated the panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 7: Advanced Prostate Cancer

Efficacy of Enzalutamide Plus ADT in Men with De Novo (M1) mHSPC Versus Progression to mHSPC: Post Hoc Analysis of the Phase III ARCHES Trial

Daniel P. Petrylak, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Final Results from ACIS Trial of Apalutamide Plus Abiraterone/Prednisone in Patients (pts) with Chemo-Naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Raoul S. Concepcion, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Safety of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer From Extended Follow-Up in the Phase III ARAMIS Trial

Raoul S. Concepcion, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Role of PARP Inhibitors

Daniel P. Petrylak, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Recent Advancement in the Treatment of Metastatic Castration Sensitive Prostate Cancer (mCSPC

Neeraj Agarwal, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion – Advanced Prostate Cancer

Daniel P. Petrylak, MD, moderated the panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 8: Prostate Cancer: Breaking News

Real World Utilization of Guideline Based Therapy in mCSPC: Update from the 2021 ASCO Annual Meeting

Neeraj Agarwal, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Phase 3 VERACITY Study: Sabizabulin, an Oral Targeted Androgen Receptor Transport Disruptor to Treat Men with Metastatic Castration Resistant Prostate Cancer Who Progressed on an Androgen Receptor Targeting Agent

Mitchell Steiner, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Updates on PSMA-imaging and PSMA-CAR-T Therapy

Daniel P. Petrylak, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

GUIDE: A New Initiative for a National Biorepository

E. David Crawford, MD, and Matthew O. Leavitt, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion – Prostate Cancer: Breaking News

Raoul S. Concepcion, MD, FACS, moderated the panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

SESSION 9: Targeted Focal Therapy

MRI-Guided Focal Therapy: Initial Quality-of-Life and Oncologic Outcomes

James A. Eastham, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Transperineal Prostate Biopsy: A New Standard of Care?

Michael A. Gorin, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Recent Innovations in MRI-Guided Prostate Biopsy

Michael A. Gorin, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion – Targeted Focal Therapy

Thomas J. Polascik, MD, FACS, moderated the panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Update on New Approaches Combining Brachytherapy with Immunotherapy

Steven E. Finkelstein, MD, FACRO, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

High Intensity Focused Ultrasound (HIFU)

Arvin George, MD, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Focal Cryosurgery: Outcomes and Observations

Thomas J. Polascik, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Surveillance After Image-Targeted Focal Therapy

Thomas J. Polascik, MD, FACS, presented this lecture during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Panel Discussion

Thomas J. Polascik, MD, FACS, moderated the panel during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Poster Session – Oral Presentations

Deciphering the Changing Landscape of Differential Delay in Cancer Diagnoses in Community Radiation and Medical Oncology

Mitchell O. Finkelstein (high school research intern), presented this presentation during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

The Diagnostic Performance of Piflufolastat F 18 (PYLARIFY®) PET/CT in High-Risk and Recurrent Prostate Cancer: Results from the OSPREY and CONDOR Clinical Trials 

Jaylyn Victoria, presented this presentation during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

A Phase 3, Randomized, Open-Label Study (CONTACT-02) Of Cabozantinib Plus Atezolizumab Versus Second Novel Hormone Therapy (NHT) In Patients (Pts) With Metastatic, Castration-Resistant Prostate Cancer (mCRPC)

Neeraj Agarwal, presented this presentation during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Phase 1b/2 Study of Sabizabulin (VERU-111), an Androgen Receptor Transport Disruptor, in Men With Metastatic Castration Resistant Prostate Cancer (mCRPC) Who Failed an Androgen Receptor Targeting Agent (ARTA)